Genetic association of CTNNA3 with late-onset Alzheimer's disease in females

Human Molecular Genetics

Volumn 16, Issue 23, 2007, Pages 2854-2869

  Miyashita, Akinori ^a   Arai, Hiroyuki ^b   Asada, Takashi ^c   Imagawa, Masaki ^d   Matsubara, Etsuro ^e   Shoji, Mikio ^f   Higuchi, Susumu ^g   Urakami, Katsuya ^h   Kakita, Akiyoshi ^a   Takahashi, Hitoshi ^a   Toyabe, Shinichi ^a,l   Akazawa, Kohei ^a   Kanazawa, Ichiro ⁱ   Ihara, Yasuo ^j,m   Kuwano, Ryozo ^a,k  

^a NIIGATA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Imagawa Clinic   (Japan)

^e NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g KURIHAMA NATIONAL HOSPITAL   (Japan)

^h TOTTORI UNIVERSITY   (Japan)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

^k Niigata University Medical and Dental Hospital ^*  (Japan)

^l NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^m DOSHISHA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E3;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; DATA ANALYSIS; DEMENTIA; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; HYPOTHESIS; INTRON; LINKAGE ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALPHA CATENIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 35748957469     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm244     Document Type: Article

References (68)

1. Bachman, D.L., Wolf, P.A., Linn, R., Knoefel, J.E., Cobb, J., Belanger, A., D'Agostino, R.B. and White, L.R. (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology, 42, 115-119.
2. Hy, L.X. and Keller, D.M. (2000) Prevalence of AD among whites: A summary by levels of severity. Neurology, 55, 198-204.
3. Nakamura, S., Shigeta, M., Iwamoto, M., Tsuno, N., Niina, R., Homma, A. and Kawamuro, Y. (2003) Prevalence and predominance of Alzheimer type dementia in rural Japan. Psychogeriatrics, 3, 97-103.
4. Andersen, K., Launer, L.J., Dewey, M.E., Letenneur, L., Ott, A., Copeland, J.R., Dartigues, J.F., Kragh-Sorensen, P., Baldereschi, M., Brayne, C. et al. (1999) Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology, 53, 1992-1997.
5. Fratiglioni, L., Launer, L.J., Andersen, K., Breteler, M.M., Copeland, J.R., Dartigues, J.F., Lobo, A., Martinez-Lage, J., Soininen, H., Hofman, A. and Neurologic Diseases in the Elderly Research Group (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology, 54 (Suppl. 5), S10-S15.
6. Fujishima, M. and Kiyohara, Y. (2002) Incidence and risk factors of dementia in a defined elderly Japanese population: The Hisayama study. Ann. NY Acad. Sci., 977, 1-8.
7. Kukull, W.A., Higdon, R., Bowen, J.D., McCormick, W.C., Teri, L., Schellenberg, G.D., van Belle, G., Jolley, L. and Larson, E.B. (2002) Dementia and Alzheimer disease incidence: A prospective cohort study. Arch. Neurol., 59, 1737-1746.
8. Edland, S.D., Rocca, W.A., Petersen, R.C., Cha, R.H. and Kokmen, E. (2002) Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch. Neurol., 59, 1589-1593.
9. Gatz, M., Fiske, A., Reynolds, C.A., Wetherell, J.L., Johansson, B. and Pedersen, N.L. (2003) Sex differences in genetic risk for dementia. Behav. Genet., 33, 95-105.
10. Maes, O.C., Xu, S., Yu, B., Chertkow, H.M., Wang, E. and Schipper, H.M. (2006) Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging, doi:10.1016/ j.neurobiolaging.2006.08.004.
11. Assini, A., Cammarata, S., Vitali, A., Colucci, M., Giliberto,L., Borghi, R., Inglese, M.L., Volpe, S., Ratto, S., Dagna-Bricarelli, F. et al. (2004) Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology, 63, 828-831.
12. Wang, J., Tanila, H., Puolivali, J., Kadish, I. and van Groen, T. (2003) Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol. Dis., 14, 318-327.
13. van Groen, T., Kiliaan, A.J. and Kadish, I. (2006) Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. Neurobiol. Dis., 23, 653-662.
14. Maynard, C.J., Cappai, R., Volitakis, I., Cherny, R.A., Masters, C.I., Li, Q.X. and Bush, A.I. (2006) Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer beta-amyloid pathology. J. Inorg. Biochem., 100, 952-962.
15. Schafer, S., Wirths, O., Multhaup, G. and Bayer, T.A. (2007) Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J Neural Transm., 114, 387-394.
16. Kamboh, M.I., Sanghera, D.K., Aston, C.E., Bunker, C.H., Hamman, R.F., Ferrell, R.E. and DeKosky, S.T. (1997) Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet. Epidemiol., 14, 169-180.
17. Reynolds, W.F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R.A. and Masliah, E. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol., 155, 31-41.
18. Crawford, F.C., Freeman, M.J., Schinka, J.A., Morris, M.D., Abdullah, L.I., Richards, D., Sevush, S., Duara, R. and Mullan, M.J. (2001) Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene. Exp. Neurol., 167, 456-459.
19. Crawford, F., Abdullah, L., Schinka, J., Suo, Z., Gold, M., Duara, R. and Mullan, M. (2000) Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci. Lett., 280, 215-219.
20. Pirskanen, M., Hiltunen, M., Mannermaa, A., Helisalmi, S., Lehtovirta, M., Hanninen, T. and Soininen, H. (2005) Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur. J. Hum. Genet., 13, 1000-1006.
21. Ramos, M.C., Tenorio, R., Martinez-Garcia, A., Sastre, I., Vilella-Cuadrada, E., Frank, A., Rosich-Estrago, M., Valdivieso, F. and Bullido, M.J. (2006) Association of DSC1, a gene modulated by adrenergic stimulation, with Alzheimer's disease. Neurosci. Lett., 408, 203-208.
22. Sundar, P.D., Feingold, E., Minster, R.L., Dekosky, S.T. and Kamboh, M.I. (2006) Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol. Aging, doi:10.1016/ j.neurobiolaging.2006.04.005.
23. Ertekin-Taner, N., Graff-Radford, N., Younkin, L.H., Eckman, C., Baker, M., Adamson, J., Ronald, J., Blangero, J., Hutton, M. and Younkin, S.G. (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science, 290 2303-2304.
24. Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramic, D., Shears, S., Booth, J., DeVrieze, F.W., Crook R. et al. (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. Science, 290, 2304-2305.
25. Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, M.G., Go, R.C., Vekrellis, K. et al. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science, 290, 2302-2303.
26. Kuwano, R., Miyashita, A., Arai, H., Asada, T., Imagawa, M., Shoji, M., Higuchi, S., Urakami, K., Kakita, A., Takahashi, H. et al. (2006). Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Hum. Mol. Genet., 15, 2170-2182.
27. Bassett, S.S., Avramopoulos, D. and Fallin, D. (2002) Evidence for parent of origin effect in late-onset Alzheimer disease. Am. J. Med. Genet., 114, 679-686.
28. Bassett, S.S., Avramopoulos, D., Perry, R.T., Wiener, H., Watson, B., Jr., Go, R.C. and Fallin, M.D. (2006) Further evidence of a maternal parent-of-origin effect on chromosome 10 in late-onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet, 141, 537-540.
29. Janssens, B., Goossens, S., Staes, K., Gilbert, B., van Hengel, J., Colpaert, C., Bruyneel, E., Mareel, M. and van Roy, F. (2001) AlphaT-catenin: A novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion. J. Cell. Sci., 114, 3177-3188.
30. Janssens, B., Mohapatra, B., Vatta, M., Goossens, S., Vanpoucke, G., Kools, P., Montoye, T., van Hengel, J., Bowles, N.E., van Roy, F. et al. (2003) Assessment of the CTNNA3 gene encoding human alpha T-catenin regarding its involvement in dilated cardiomyopathy. Hum. Genet., 112, 227-236.
31. Zhang, Z., Hartmann, H., Do, V.M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P. et al. (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature, 395, 698-702.
32. Ertekin-Taner, N., Ronald, J., Asahara, H., Younkin, L., Hella, M., Jain, S., Gnida, E., Younkin, S., Fadale, D., Ohyagi, Y. et al. (2003) Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Hum. Mol. Genet., 12, 3133-3143.
33. Busby, V., Goossens, S., Nowotny, P., Hamilton, G., Smemo, S., Harold, D., Turic, D., Jesus, L., Myers, A., Womick, M. et al. (2004) Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease. Neuromolecular Med., 5, 133-146.
34. Blomqvist, M.E., Andreasen, N., Bogdanovic, N., Blennow, K., Brookes, A.J. and Prince, J.A. (2004) Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease. Neurosci. Lett., 358 220-222.
35. Martin, E.R., Bronson, P.G., Li, Y.J., Wall, N., Chung, R.H., Schmechel, D.E., Small, G., Xu, P.T., Bartlett, J., Schnetz-Boutaud, N. et al. (2005) Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease. J. Med. Genet., 42, 787-792.
36. Cellini, E., Bagnoli, S., Tedde, A., Nacmias, B., Piacentini, S. and Sorbi, S. (2005) Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease. Alzheimer Dis. Assoc. Disord., 19, 246-247.
37. Bertram, L., Mullin, K., Parkinson, M., Hsiao, M., Moscarillo, T.J., Wagner, S.L., Becker, K.D., Velicelebi, G., Blacker, D. and Tanzi, R.E. (2007) Is alpha-T catenin (VR22) an Alzheimer's disease risk gene? J. Med. Genet., 44, e63.
38. International HapMap Consortium (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
39. Murayama, M., Tanaka, S., Palacino, J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B. and Takashima, A. (1998) Direct association of presenilin-1 with beta-catenin. FEBS Lett., 433, 73-77.
40. Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D.M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M. et al. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J. Biol. Chem., 273, 16470-16475.
41. Nishimura, M., Yu, G., Levesque, G., Zhang, D.M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T. et al. (1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat. Med., 5, 164-169.
42. De Ferrari, G.V. and Inestrosa, N.C. (2000) Wnt signaling function in Alzheimer's disease. Brain Res. Rev., 33, 1-12.
43. De Ferrari, G.V. and Moon, R.T. (2006) The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene, 25, 7545-7553.
44. Tokuhiro, S., Yamada, R., Chang, X., Suzuki, A., Kochi, Y., Sawada, T., Suzuki, M., Nagasaki, M., Ohtsuki, M., Ono, M. et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet., 35, 341-348.
45. Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W. et al. (2006) Global variation in copy number in the human genome. Nature 444, 444-454.
46. Feuk, L., Marshall, C.R., Wintle, R.F. and Scherer, S.W. (2006) Structural variants: Changing the landscape of chromosomes and design of disease studies. Hum. Mol. Genet., 15 (Spec. No. 1), R57-R66.
47. van Dijk, M., Mulders, J., Konst, A., Janssens, B., van Roy, F., Blankenstein, M. and Oudejans, C. (2004) Differential downregulation of alpha T-catenin expression in placenta: Trophoblast cell type-dependent imprinting of the CTNNA3 gene. Gene Expr. Patterns, 5, 61-65.
48. Nikaido, I., Saito, C., Wakamoto, A., Tomaru, Y., Arakawa, T., Hayashizaki, Y. and Okazaki, Y. (2004) EICO (Expression-based Imprint Candidate Organizer): Finding disease-related imprinted genes. Nucleic Acids Res., 32, D548-D551.
49. Nikaido, I., Saito, C., Mizuno, Y., Meguro, M., Bono, H., Kadomura, M., Kono, T., Morris, G.A., Lyons, P.A., Oshintura, M. et al. (2003) Discovery of imprinted transcripts in the mouse transcriptome using large-scale expression profiling. Genome Res., 13, 1402-1409.
50. Luedi, P.P., Hartemink, A.J. and Jirtle, R.L. (2005) Genome-wide prediction of imprinted murine genes. Genome Res., 15, 875-884.
51. Isles, A.R. and Wilkinson, L.S. (2000) Imprinted genes, cognition and behaviour. Trends Cogn. Sci., 4, 309-318.
52. Morison, I.M., Ramsay, J.P. and Spencer, H.G. (2005) A census of mammalian imprinting. Trends Genet., 21, 457-465.
53. Davies, W., Isles, A.R. and Wilkinson, L.S. (2005) Imprinted gene expression in the brain. Neurosci. Biobehav. Rev., 29, 421-430.
54. Ozaki, K., Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y. et al. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet., 32, 650-654.
55. Li, Y., Nowotny, P., Holmans, P., Smemo, S., Kauwe, J.S., Hinrichs, A.L., Tacey, K., Doil, L., van Luchene, R., Garcia, V. et al. (2004) Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. USA, 101, 15688-15693.
56. Grupe, A., Li Y., Rowland, C., Nowotny, P., Hinrichs, A.L., Smemo, S., Kauwe, J.S., Maxwell, T.J., Cherny, S., Doil, L. et al. (2006) A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am. J. Hum. Genet., 78, 78-88.
57. Li, Y., Grupe, A., Rowland, C., Nowotny, P., Kauwe, J.S., Smemo, S., Hinrichs, A., Tacey, K., Toombs, T.A., Kwok, S. et al. (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum. Mol. Genet., 15, 2560-2568.
58. Sato, Y., Suganami, H., Hamada, C., Yoshimura, I., Yoshida, T. and Yoshimura, K. (2004) Designing a multistage, SNP-based, genome screen for common diseases. J. Hum. Genet., 49, 669-676.
59. Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otovos, L., Eckman, C., Golde, T.E. and Younkin, S.G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science, 264, 1336-1340.
60. Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C. and Suzuki, N. (1995) Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry, 32, 10272-10278.
61. Matsubara, E., Ghiso, J., Frangione, B., Amari, M., Tomidokoro, Y., Ikeda, Y., Harigaya, Y., Okamoto, K. and Shoji, M. (1999 Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome. Ann. Neurol., 45, 537-541.
62. Gun, S.W. and Thompson, E.A. (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 48 361-372.
63. Mantel, N. and Haenszel, W. (195 9) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719-748.
64. Excoffier, L. and Slatkin, M. (1995) Maximurn-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
65. Fallin, D., Cohen, A., Essioux, L., Churnakov, I., Blumenfeld, M., Cohen, D. and Schork, N.J. (2001) Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease. Genome Res., 11, 143-151.
66. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
67. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
68. Akazawa, K., Nakamura, T. and Palesch, Y. (1997) Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat. Med., 16, 583-597.